2021
DOI: 10.1016/j.plipres.2020.101083
|View full text |Cite
|
Sign up to set email alerts
|

Reprogramming microorganisms for the biosynthesis of astaxanthin via metabolic engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
67
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(67 citation statements)
references
References 267 publications
0
67
0
Order By: Relevance
“…Only the Xanthophyllomyces dendrorhous strains capable of astaxanthin synthesis 5- to 10-fold higher than in wild strains may be used for industrial production of the pigment and greatly reduce its market price [ 82 , 85 ]. Such strains can be obtained with chemical mutagenesis [ 86 ] or with a combination of classical mutagenesis and genetic pathway engineering [ 87 , 88 ].…”
Section: Commercial Sources Of Astaxanthinmentioning
confidence: 99%
“…Only the Xanthophyllomyces dendrorhous strains capable of astaxanthin synthesis 5- to 10-fold higher than in wild strains may be used for industrial production of the pigment and greatly reduce its market price [ 82 , 85 ]. Such strains can be obtained with chemical mutagenesis [ 86 ] or with a combination of classical mutagenesis and genetic pathway engineering [ 87 , 88 ].…”
Section: Commercial Sources Of Astaxanthinmentioning
confidence: 99%
“…As can be inferred from previous paragraphs, the main producers of this pigment are the yeast X. dendrorhous and the microalgae H. pluvialis [ 1 , 12 , 26 30 ]. Nevertheless, microbial production of astaxanthin is less competitive than the synthetic one because of difficulties to obtain enough biomass and its low pigment yield, thus overproducing astaxanthin from appropriate microbial sources is a current biotechnological challenge [ 1 , 12 , 31 ]. So far, bioengineering approaches that include culture media and bioreactor optimization [ 30 ], as well as construction of improved overproducing strains [ 12 , 31 , 32 ], have been assayed.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, microbial production of astaxanthin is less competitive than the synthetic one because of difficulties to obtain enough biomass and its low pigment yield, thus overproducing astaxanthin from appropriate microbial sources is a current biotechnological challenge [ 1 , 12 , 31 ]. So far, bioengineering approaches that include culture media and bioreactor optimization [ 30 ], as well as construction of improved overproducing strains [ 12 , 31 , 32 ], have been assayed. Metabolic engineering of Saccharomyces cerevisiae , Candida utilis , Pichia pastoris and X. dendrorhous have led to increased amounts of phytoene, lycopene or β-carotene, but they have failed to increase astaxanthin biosynthesis in relevant levels [ 1 , 30 , 33 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…These supplements are taken for many different reasons, including improving eye health and vision, skin health, and enhancing athletic performance by speeding muscle recovery after exercise. The global market for AST is rapidly increasing; however, the bulk of AST available is produced synthetically, providing an opportunity for marketing a natural product [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…and red yeast Xanthophyllomyces dendrorhous (also known as Pfaffia rhodozyma) [3,[11][12][13][14]. It was reported that the current commercialized (3S,3 S)-astaxanthin used as a fish additive is mainly produced by P. carotinifaciens [8]. More recently, people also have tried to engineer AST-producing plants by introducing genes from bacterial and algal pathways [15][16][17], although successful mass production has not yet been achieved.…”
Section: Introductionmentioning
confidence: 99%